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M3Lung-Sys: A Deep Learning System for
Multi-Class Lung Pneumonia Screening from CT
Imaging
Xuelin Qian, Huazhu Fu, Weiya Shi, Tao Chen, Yanwei Fu, Fei Shan, and Xiangyang Xue
Abstract— To counter the outbreak of COVID-19, the ac-
curate diagnosis of suspected cases plays a crucial role
in timely quarantine, medical treatment, and preventing the
spread of the pandemic. Considering the limited training
cases and resources (e.g, time and budget), we propose a
Multi-task Multi-slice Deep Learning System (M3Lung-Sys)
for multi-class lung pneumonia screening from CT imaging,
which only consists of two 2D CNN networks, i.e., slice-
and patient-level classification networks. The former aims
to seek the feature representations from abundant CT slices
instead of limited CT volumes, and for the overall pneu-
monia screening, the latter one could recover the temporal
information by feature refinement and aggregation between
different slices. In addition to distinguish COVID-19 from
Healthy, H1N1, and CAP cases, our M3Lung-Sys also be
able to locate the areas of relevant lesions, without any
pixel-level annotation. To further demonstrate the effective-
ness of our model, we conduct extensive experiments on a
chest CT imaging dataset with a total of 734 patients (251
healthy people, 245 COVID-19 patients, 105 H1N1 patients,
and 133 CAP patients). The quantitative results with plenty
of metrics indicate the superiority of our proposed model
on both slice- and patient-level classification tasks. More
importantly, the generated lesion location maps make our
system interpretable and more valuable to clinicians.
Index Terms— COVID-19, CT imaging, Deep learn-
ing, Multi-class pneumonia screening, Weakly-supervised
learning, Lesion localization
I. INTRODUCTION
Coronavirus disease 2019 (COVID-19), caused by a novel
coronavirus (SARS-CoV-2, previously known as 2019-nCoV),
is highly contagious and has become increasingly prevalent
worldwide. The disease may lead to acute respiratory distress
or multiple organ failure in severe cases [1], [2]. As of June
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Fig. 1: Typical images of COVID-19, H1N1 and CAP. The
red arrows indicate the locations of different lesions, which are
marked by clinical experts. (a) COVID-19: CT shows ground
glass opacity (GGO) with consolidation and crazy-paving sign
distributed mainly along subpleural lungs. (b) H1N1(influenza
A(H1N1)pdm09): the consolidation and small centrilobular
nodules mainly locate at bronchovascular bundles. (c) CAP:
there exists segmental consolidation with GGO.
28th, 2020, 495, 760 of 9, 843, 073 confirmed cases across
countries have led to death, according to WHO statistics.
Thus, how to accurately and efficiently diagnose COVID-
19 is of vital importance not only for the timely treatment
of patients, but also for the distribution and management of
hospital resources during the outbreak.
The standard diagnostic method being used is real-time
polymerase chain reaction (RT-PCR), which detects viral nu-
cleotides from specimens obtained by oropharyngeal swab,
nasopharyngeal swab, bronchoalveolar lavage, or tracheal aspi-
rate [3]. Early reports of RT-PCR sensitivity vary considerably,
ranging from 42% to 71%, and an initially negative RT-PCR
result may convert into COVID-19 after up to four days [4].
Recent studies have shown that typical Computed Tomogra-
phy (CT) findings of COVID-19 include bilateral pulmonary
parenchymal groundglass and consolidative pulmonary opaci-
ties, with a peripheral lung distribution [5], [6]. In contrast to
RT-PCR, chest CT scans have demonstrated about 56∼98%
sensitivity in detecting COVID-19 at initial manifestation and
can be helpful in rectifying false negatives obtained from RT-
PCR during early stages of disease development [7], [8].
However, CT scans also share several similar visual mani-
festations between COVID-19 and other types of pneumonia,
thus making it difficult and time-consuming for doctors to dif-
ferentiate among a mass of cases, resulting in about 25∼53%
specificity [4], [7]. Among them, CAP (community-acquired
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pneumonia) and influenza pneumonia are the most common
types of pneumonia, as shown in Figure 1; therefore, it is
essential to differentiate COVID-19 pneumonia from these.
Recently, Liu et al. compared the chest CT characteristics of
COVID-19 pneumonia with influenza pneumonia, and found
that COVID-19 pneumonia was more likely to have a periph-
eral distribution, with the absence of nodules and tree-in-bud
signs [9]. Lobar or segmental consolidation with or without
cavitation is common in CAP [10]. Although it is easy to
identify these typical lesions, the CT features of COVID-19,
H1N1 and CAP pneumonia are very diverse.
In the past few decades, artificial intelligence using deep
learning (DL) technology has achieved remarkable progress
in various computer vision tasks [11]–[15]. Recently, the
superiority of DL has made it widely favored in medical image
analysis. Specifically, several studies focus on classifying
different diseases, such as autism spectrum disorder [16],
[17] or Alzheimer’s disease in the brain [18]–[20]; breast
cancers [21]–[23]; diabetic retinopathy and Glaucoma in the
eye [24]–[26]; and lung cancer [27], [28] or pneumonia [29],
[30] in the chest. Some efforts have also been made to partition
images, from different modalities (e.g., CT, X-ray, MRI) into
different meaningful segments [31]–[33], including pathology,
organs or other biological structures.
Existing studies [30], [34], [35] have demonstrated the
promising performance of applying deep learning technology
for COVID-19 diagnosis. However, as initial studies, several
limitations have emerged from these works. First of all, [36]–
[39] utilized pixel-wise annotations for segmentation, which
require taxing manual labeling. This is unrealistic in practice,
especially in the event of an infectious disease pandemic.
Second, performing diagnosis or risk assessment on only
slice-level CT images [34], [40]–[45] is of limited value to
clinicians. Since a volumetric CT exam normally includes
hundreds of slices, it is still inconvenient for clinicians to
go through the predicted result of each slice one by one.
Although, 3D Convolutional Neural Networks (3D CNNs) are
one option for tackling these limitations, their high hardware
requirements, computational costs (e.g., GPUs) and training
time, make them inflexible for applications [43], [46], [47].
To this end, we propose a Multi-task Multi-slice Deep
Learning System (M3Lung-Sys) for multi-class lung pneumo-
nia screening, which can jointly diagnose and locate COVID-
19 from chest CT images. Using the only category labeled
information, our system can successfully distinguish COVID-
19 from H1N1, CAP and healthy cases, and automatically
locate relevant lesions on CT images (e.g., GGO) for better in-
terpretability, which is more important for assisting clinicians
in practice. To facilitate the above objective, two networks
using a 2D CNN are devised in our system. The first one is a
slice-level classification network, which acts like a radiologist
to diagnose from coarse (normal or abnormal) to fine (disease
categories) for every single CT slice. As the name suggests,
it can ignore the temporal information among CT volumes
and focus on the spatial information among pixels in each
slice. Meanwhile, the learned spatial features can be further
leveraged to locate the abnormalities without any annotation.
To recover the temporal information and provide more value to
Category Patient-level Slice-level Age SexTrain Test Train Test (M/F)
Healthy 149 102 42,834 30,448 32.4±11.8 131/120
COVID-19 149 96 18,919 13,382 51.5±15.9 143/102
H1N1 64 41 1,098 883 28.5±14.6 62/43
CAP 80 53 7,067 4,105 48.5±17.4 79/54
TABLE I: Summary of training and testing sets.
clinicians, we introduce a novel patient-level classification net-
work, using specifically designed refinement and aggregation
modules, for diagnosis from CT volumes. Taking advantage
of the learned spatial features, the patient-level classification
network can be trained easily and efficiently.
In summary, the contributions of this paper are four-fold: 1)
We propose an M3Lung-Sys for multi-class lung pneumonia
screening from CT images. Specifically, it can distinguish
COVID-19 from healthy, H1N1 and CAP cases on either a sin-
gle CT slice or CT volumes of patients. 2) In addition to pre-
dicting the probability of pneumonia assessment, our M3Lung-
Sys is able to simultaneously output the lesion localization
maps for each CT slice, which is valuable to clinicians for
diagnosis, allowing them to understand why our system gives
a particular prediction, rather than simply being fed a statistic.
3) Compared with 3D CNN based approaches [47], [48], our
proposed system can achieve competitive performance with a
cheaper cost and without requiring large-scale training data
1. 4) Extensive experiments are conducted on a multi-class
pneumonia dataset with 251 healthy people, 245 COVID-19
patients, 105 H1N1 patients and 133 CAP patients. We achieve
high accuracy of 95.21% for correctly screening the multi-
class pneumonia testing cases. The quantitative and qualitative
results demonstrate that our system has great potential to be
applied in clinical application.
II. DATASET
A. Patients
The Ethics Committee of Shanghai Public Health Clinical
Center, Fudan University approved the protocol of this study
and waived the requirement for patient-informed consent (YJ-
2020-S035-01). A search through the medical records in our
hospital information system was conducted, with the final
dataset consisting of 245 patients with COVID-19 pneumo-
nia, 105 patients with H1N1 pneumonia, 133 patients with
CAP and 251 healthy subjects with non-pneumonia. Of the
734 enrolled people with 415 (56.5%) men, the mean age
was 41.8±15.9 years (range, 2 ∼ 96 years). The patient
demographic statistics are summarized in Table I. The avail-
able CT scans were directly downloaded from the hospi-
tal Picture Archiving and Communications Systems (PACS)
and non-chest CTs were excluded. Consequently, 734 three-
dimensional (3D) volumetric chest CT exams are acquired for
our algorithm study.
1Large scale of patient-level training cases, which are required for 3D CNN
based methods, are very difficult to access due to various complex factors,
e.g., time limitation and patient privacy. However, a small scale of CT volumes
can provide plenty of slice-level samples with category labels, which can be
utilized in a 2D CNN system.
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Fig. 2: The flow chart of patient selection.
All the COVID-19 cases (mean age, 51.5 ± 15.9 years;
range, 16 ∼ 83 years) and H1N1 cases (mean age, 28.5±14.6
years; range, 4 ∼ 78 years) were acquired from January 20
to February 24, 2020 and from May 24, 2009 to January 18,
2010, respectively. All patients were diagnosed according to
the diagnostic criteria of the National Health Commission of
China and confirmed by RT-PCR detection of viral nucleic
acids. Patients with normal CT imaging were excluded.
The patients with CAP subjects (mean age, 48.5 ± 17.4
years; range, 8 ∼ 96 years) and healthy subjects (mean age,
32.4± 11.8 years; range, 2 ∼ 73 years) with non-pneumonia
were randomly selected between January 3, 2019 and January
30, 2020. All the CAP cases were confirmed positive by
bacterial culture, and healthy subjects with non-pneumonia
undergoing physical examination had normal CT imaging.
B. Selection and Annotation
To better improve the algorithm framework and fairly
demonstrate the performance, we do not use any CT volumes
from re-examination, that is, only one 3D volumetric CT exam
per patient is enrolled in our dataset. As shown in Figure 2,
all eligible patients were then randomized into a training set
and testing set, respectively, using random computer-generated
numbers. Unlike other studies [45], [47] which employ a
small number of cases (10%∼15%) for testing, we utilize
around 40% of each category to evaluate the effectiveness and
practicability of our system.
The annotation was performed at a patient and slice level.
First of all, each CT volume was automatically labeled with
a one-hot category vector based on CT reports and clinical
diagnosis (i.e., 0: Healthy; 1: COVID-19; 2: H1N1; 3: CAP).
Considering that each volumetric exam contains 512 × 512
images with a varying number of slices from 24∼495, for
training, five experts subsequently annotated each CT slice
following four principles: (1) The quality of annotation is
supervised by a senior clinician; (2) If a slice is determined to
have any lesion, label it with the corresponding CT volume’s
category; (3) Except for healthy cases, all slices from other
cases considered as normal are discarded; (4) All slices from
healthy people are annotated as Healthy. Note that we evaluate
our model with the whole CT volume (i.e., realistic and
arbitrary-length data), the discarded slices are only removed
for training. Eventually, the number of slices annotated for
the four categories is listed in Table I. The training set
was used for algorithm development [n=442; healthy person,
n=149; COVID-19 patients, n=149; H1N1 patients, n=64; CAP
patients, n=80], and the testing set was used for algorithm
testing [n=292; healthy person, n=102; COVID-19 patients,
n=96; H1N1 patients, n=41; CAP patients, n=53].
III. METHODOLOGY
Figure 3 shows the schematic of our proposed Multi-
task Multi-slice Deep Learning System (M3Lung-Sys), which
consists of two components, the Image Preprocessing and
Classification Network. Specifically, the Image Preprocessing
receives raw CT exams, and prepare them for model training
or inference (in Section III-A). For the Classification Net-
work, we divide it into two subnets (stages), i.e., slice-level
and patient-level classification networks, with the purpose of
jointly COVID-19 screening and location. Concretely, slice-
level classification network is trained with multiple CT slice
images and predicts the corresponding slice-level categories
(in Section III-B), i.e., Healthy, COVID-19, H1N1 or CAP.
Besides, patient-level classification network only has four
layers, and takes a volume of CT slice features, instead of
images as input, which are extracted by the former network,
to output the patient-level labels (in Section III-C). Both
classification networks are trained separately due to different
tasks, but can be used concurrently in an end-to-end manner
for the efficiency. More importantly, for cases classified as
positive (i.e., COVID-19, H1N1 or CAP), our system can
locate suspected area of abnormality without any pixel-level
annotations (in Section III-B).
A. Image Preprocessing
The pixel value of CT images reflects the absorption rate
of different human tissues (e.g., bone, lung, kidney) to x-
rays, which is measured by Hounsfield Unit (HU) [49]. If
we directly apply raw images for classification, this will
inevitably introduce noise or irrelevant information, such as
the characteristics of equipment, making the performance of
the model inaccurate and unreliable. Consequently, according
to the priors from radiologist, here, we introduce two effective
yet straightforward approaches for preprocessing.
1) Lung Crop: Given chest CT images, lungs are one of
the most important organs observed by radiologists to check
whether there exist abnormalities. Considering the extreme
cost and time-consumption of manual labeling, instead of
training an extra deep learning network for lung segmenta-
tion [47], [48], [50], we propose a hand-crafted algorithm to
automatically subdivide/segment the image into ‘lungs’ and
‘other’, and then crop the area of lungs using the minimum
bounding rectangle within a given margin. As illustrated
in Figure 4, the details of the algorithm involved in lung
segmentation and cropping are as following:
• Step 1: Load the raw CT scan image (Figure 4 (a)).
4 M3LUNG-SYS: A DEEP LEARNING SYSTEM FOR MULTI-CLASS LUNG PNEUMONIA SCREENING FROM CT IMAGING
Fig. 3: The schematic of our M3Lung-Sys. The red/black arrows indicate the training/inference phases. Both classification
networks are trained separately due to different tasks, but can be used concurrently in an end-to-end manner. The details of
the classification networks are illustrated in Figure 5 and Figure 6.
Fig. 4: Detailed procedures of lung cropping during image
preprocessing.
• Step 2: Set a threshold to separate the lung area from
others, such as bone and fat (Figure 4 (b)). In this paper,
we set the threshold of HU as THU = −300.
• Step 3: To alleviate the effect of ‘trays’, which the patient
lays on during CT scanning, we apply a morphological
opening operation [51] (Figure 4 (c)). Specifically, we set
the kernel size as 1× 8.
• Step 4: Remove the background (e.g., trays, bone and
fat) based on 8-Connected Components Labeling [52]
(Figure 4 (d)).
• Step 5: Apply the morphological opening operation again
to eliminate the noise caused by Step 3 (Figure 4 (e)).
• Step 6: Compute the minimum bounding rectangle with
a margin of 10 pixels for lung cropping and then resize
the cropped image (Figure 4 (f)).
2) Multi-value Window-leveling: In order to simulate the
process of window-leveling when a radiologist is looking at
CT scans, we further apply multi-value window-leveling to
all images. More concretely, the value of the window center
is assigned randomly from −700 to −500, and the window
width is assigned with a constant of 1200. This preprocessing
provides at least two benefits: (1) generating much more CT
samples for training, i.e., data augmentation; (2) during in-
ference, the assessment based on multi-value window-leveling
CT images will be more accurate and reliable.
B. Slice-level Classification Network
After the above-mentioned image preprocessing, slices from
CT volumes are first fed into the slice-level classification
network. Considering the outstanding performance achieved
by the residual networks (ResNets) [53] on the 1000-category
image classification task, we utilize ResNet-50 [53] as our
backbone and initialize it with the ImageNet [54] pre-
trained weights. This network consists of four blocks (a.k.a,
ResBlock1∼4) with a total of 50 layers, including convolu-
tional layers and fully connected layers. Each block has a
similar structure, but different number of layers. The skip
connection and identity mapping functions in the blocks make
it more possible to apply deeper layers to learn stronger
representations. For the purpose of pneumonia classification
and alleviating the limitations discussed in Section I, we im-
prove the network from three aspects, i.e., multi-task learning
for radiologist-like diagnosis, weakly-supervised learning for
slice-level lesion localization (attention) and coordinate maps
for learning location information, as shown in Figure 5.
1) Multi-task Learning: Usually, given a CT slice, a radiolo-
gist will gradually check for abnormalities and make a decision
according to these. To act like an experienced radiologist, we
introduce a multi-task learning scheme [55] by dividing the
network into two stages. Specifically, image features obtained
from the first three ResBlocks are fed into an extra classifier to
determine whether they have any lesion characteristics. Then,
the features are further passed through ResBlock4 to determine
fine-grained category, i.e., Healthy, COVID-19, H1N1 or CAP.
2) Weakly-supervised Learning for Lesion Localization: In-
stead of using pixel-wise annotations or bounding box labels
for learning to locate infection areas, we devise a weakly-
supervised learning approach, that is, employ only the category
labels. Specifically, the weights of the extra classifier described
in Sec. III-B.1 have a dimension of 2 × D, where D is
the dimension of the feature and ‘2’ denotes the number of
classes (i.e., ‘with lesion’ and ‘without lesion’). These learned
weights can be regarded as two prototypical features of the
corresponding two classes. Similar to the Class Activation
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Fig. 5: The details of our proposed slice-level classifica-
tion network. We improve the network from three aspects:
(1) multi-task learning to diagnose like a radiologist; (2)
weakly-supervised learning for slice-level lesion localization
(attention); (3) coordinate maps for location information. The
symbol ‘©’ indicates a concatenation operation.
Map [56], we first select one prototypical feature according
to the predicted class, and then calculate the distance between
it and each point of the image feature extracted from the
first three ResBlocks. Intuitively, a closer distance between a
point and the prototypical feature of ‘with lesion’ indicates
that the area of this point mapping to the input CT slice
has a higher probability of being an infection region, e.g.,
GGO. As one output of our M3Lung-Sys, such generated
location maps are complementary to the final predicted di-
agnosis and provide interpretability for our network, making
the assistance to clinicians more comprehensive and flexible.
More visualization samples are demonstrated in Figure 10, 11
and 12. Furthermore, we regard the lesion location map as an
attention map and take full advantage of it to help the slice-
level differential diagnosis, as shown in Figure 5.
3) Coordinate Maps: From the literature [57], it is known
that infections of COVID-19 have several spatial character-
istics. For example, they frequently distribute bilaterally on
lungs, and predominantly in peripheral lower zone. Neverthe-
less, convolutional neural networks primarily extract the fea-
tures of textures. To explicitly capture the spatial information,
and inspired by [58], we integrate our slice-level classification
network with the coordinate maps (H ×W × 3) containing
three channels, where H and W are the height and width of
the image feature extracted from the first three ResBlocks, to
facilitate the distinction among COVID-19, H1N1 and CAP.
The first two channels of the coordinate maps are instantiated
and filled with the coordinates of x ∈ [0,W ) and y ∈ [0, H)
respectively. And we further apply a normalization to make
them fall in the range of [−1, 1]. The last channel encodes
the distance d from the point (x, y) to the center (0, 0), i.e,
d =
√
x2 + y2. Specifically, these three additional channels
are fed into the ResBlock4 together with the image feature and
attention map to learn representations with spatial information.
C. Patient-level Classification Network
As mentioned in Section I, performing diagnosis or risk
assessment on only slice-level CT images is of limited value
to clinicians. Although several studies [47], [48] have been
proposed to take advantage of temporal information with
3D CNNs for patient-level differential diagnosis, they require
thousands of patient-level data for deep model training, which
Fig. 6: The details of our proposed patient-level classification
network. It takes a volume of slice-level features as input, and
feeds them into a feature refinement and aggregation head, so
that the image features from different slices can be correlated
with each other and aggregated into one final feature for
patient-level classification.
makes the cost particularly high. To overcome these limita-
tions, we further propose a patient-level classification network.
It takes a volume of CT slice-level features as input rather than
3D images, and only comprises four layers, allowing it to be
trained with lower hardware, time and data cost. Details will
be described below. Note that we concatenate the features from
ResBlock3 and ResBlock4 in Section III-B as the input.
1) Feature Refinement and Aggregation Head.: Inspired
by [12], [59], we introduce a three-layer head to conduct
feature refinement and aggregation, so that the image features
from different slices can be correlated with each other and
aggregated into one final feature for patient-level classification.
The key intuition behind this is to utilize the attention mech-
anism to exploit the correlation between different CT slices,
and accomplish the refinement and aggregation based on the
explored correlation. As shown in Figure 6, the head includes
a feature refinement module with two layers and a feature
aggregation module with one layer, the structures of which
are similar.
Formally, for the feature refinement module, given a volume
of CT image features with the feature dimension of D, we
first utilize three parallel FC layers to map the input to three
different feature spaces for dimension reduction (D
′
< D)
and self-attention [12]. Then, we calculate the distance, as
attention, between each pixel in different slices using features
from the first two spaces, and refine the features from the
last space based on the attention. Finally, another FC layer
is employed to expand the feature dimension back to D, so
that the skip-connection operation [53] can be applied. Similar
to [59], we also apply a multi-head mechanism 2 to strengthen
the refinement ability. Without loss of generality, we define the
input volume feature as F ∈ Rn×D, where n is the number of
slices, and the overall formulation of our refinement module
can be expressed as,
2The multi-head mechanism refers to the dimension of ‘h’ in Eq. 1 and 2.
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F1 = fθ1 (F) , F2 = fθ2 (F) , F3 = fθ3 (F) , (1)
H =
FT1 F2∑D′
j=1F
T
1 F2[:, j]
, with FT1 F2 ∈ Rh×D
′×D′ (2)
Fout = fθ4 (F3H) , with Fout ∈ Rn×D (3)
where H indicates the correlation between each pixel in
different slices, fθi indicates the i-th FC layer with parameter
θi, and we omit the reshape operation for simplicity.
With regard to the feature aggregation module, its structure,
as well as the equations, is similar to the refinement module,
except that we remove the multi-head mechanism and the
last FC layer, and replace the first FC layer with a learnable
parameter k ∈ R1×D′ , so that the total number of N CT image
features can be aggregated into one. Details can be found in
Figure 6 (c).
2) Multi-scale Learning: If the number of slices with lesions
in the early stage is relatively small (i.e., < N ), this may result
in key information being leaked when performing feature
aggregation from N × D to 1 × D. Therefore, we introduce
a multi-scale learning mechanism to aggregate features from
different scales. As illustrated in Figure 6 (a), given a set
of scales S = [s1, s2, . . . , sk], for each scale sj , we first
divide the input feature F ∈ RN×D evenly into sj parts,
{Fi ∈ R
N
sj
×D | i ∈ [1, 2, . . . , sj ]}. Then, a shared feature
refinement and aggregation head is applied to each part. In
the end, we concatenate a set of aggregated features from all
parts of different scales, and feed it into one FC layer to reduce
the dimension from
∑k
j=1 skD to D as the final patient-level
feature for classification.
IV. EXPERIMENTS
A. Implementation Details
We implement our framework with PyTorch [60]. All CT
slices are resized to 512×512. We set the hyper parameters of
D
′
and h as 512 and 12 respectively, and use four scales in the
feature refinement and aggregation head, i.e., S = [1, 2, 3, 4].
For training, the slice-level/patient-level classification network
is trained with two/one NVIDIA 1080Ti GPUs for a total
of 110/90 epochs, the initial learning rate is 0.01/0.001 and
gradually reduces by a factor of 0.1 every 40/30 epochs. Both
classification networks are trained separately with the standard
cross-entropy loss function. Random flipping is adopted as
data argumentation. During inference, our system is an end-
to-end framework since the input of the patient-level classi-
fication network is the output of the slice-level one, so that
it can be applied effectively. We additionally set the window
center as [−700,−600,−500] for multi-scale window-leveling
and average the final predicted features/scores for assessment.
B. Statistical Analysis
For the statistical analysis, we apply lots of metrics to
thoroughly evaluate the performance of the model, following
standard protocol. Concretely, ‘sensitivity’, known as true pos-
itive rate (TPR), indicates the percentage of positive patients
with correct discrimination. Referred as true negative rate
(TNR), ‘specificity’ represents the percentage of negative per-
sons who are correctly classified. ‘accuracy’ is the percentage
of the number of true positive (TP) and true negative (TN)
subjects. ‘false positive/negative error’ (FPE/FNE) measures
the percentage of negative/positive persons who are mis-
classified as positive/negative. ‘false disease prediction error’
(FDPE) calculates the percentage of positive persons whose
disease types (i.e., COVID-19, H1N1 or CAP) are predicted
incorrectly. Receiver operating characteristic curves (ROC)
and area under curves (AUC) are used to show the performance
of classifier. We also report the p-values compared our model
with other competitors to demonstrate the significance level 3.
C. Experimental Results
1) Patient-level Performance: The main purpose of our sys-
tem is to assist the diagnosis of COVID-19 at a patient level
rather than slice level [40]–[44], which is more significant
and practical in the real-world applications. Therefore, we first
evaluate our system on the patient-level testing set with 102
Healthy, 96 COVID-19, 41 H1N1 and 53 CAP cases. The
competitors include one 2D CNN based method of COVNet
[30] and three 3D CNN based models as Med3D-50 [61],
Med3D-18 [61] and DeCovNet [62]. The results are shown in
Table II and Figure 7.
For the overall performance, our system achieves 95.21%
on accuracy, with only 2.83% and 4.15% in false positive
error and false negative error, respectively. Although it may be
difficult for clinicians to differentiate COVID-19 from other
kinds of viral pneumonia or CAP pneumonia according to CT
features, our system, as expected, only gets confused on a
small number of cases, i.e., 1.57% in false disease prediction
error, which beats the second best model by a margin of
3.05%. Similarly, for H1N1, it obtains approximately 99.6% in
both sensitivity and specificity, which is definitely a promising
performance. Moreover, our system significantly improves the
sensitive of COVID-19 from 95% to 99% comparing with
Med3D-18 and DeCovNet. However, we observe that the
sensitivity or specificity of Healthy is relatively inferior to
Med3D-18 and DeCovNet by approximately 2∼4 points, it
seems our model is a little oversensitive to noise. On the other
hand, Med3D-50 achieves much worse performance at most of
metrics unexpectedly, especially in sharp contrast to Med3D-
18. Our explanation is that it may be difficult to train a 3D
CNN with such large parameters and limited dataset, which is
consist with our motivation of using 2D CNN based network.
In addition to performance, we also compare the computa-
tion cost between our system and other competitors. As shown
in Table III, our M3Lung-Sys takes full advantage of training
data (CT slices and volumes) and has the lowest computation
cost, including training time and GPU requirement. Combining
with the results in Table II and Table III, our method can
achieve better performance with less computing resources,
which is more practical for assisting diagnosis.
3In this paper, we utilize the method of bootstrap to sample m groups of
test sets with replacement (m is very large, 1000, for example), and then
calculate the p-values from 2×m groups of results, which are evaluated by
our model and other competitors, respectively.
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Metrics Healthy COVID-19 H1N1 CAP OverallSen. Spec. AUC Sen. Spec. AUC Sen. Spec. AUC Sen. Spec. AUC Acc. FPE FNE FDPE
COVNET 51.92 96.88 96.30 95.88 80.74 95.15 58.33 94.86 84.82 60.71 85.83 77.89 68.84 [63.70∼74.32] (p < 0.001) 48.08 3.13 18.97
Med3D-50 69.70 90.59 91.44 75.00 88.83 88.22 93.02 97.24 97.70 79.39 90.96 92.09 76.37 [71.57∼80.83] (p < 0.001) 30.30 9.41 10.45
Med3D-18 93.26 100 99.99 95.05 99.49 99.81 92.86 100 100 98.16 93.67 99.41 94.52 [91.78∼96.92] (p < 0.001) 6.74 0.00 4.62
DeCovNet 99.03 100 100 95.96 96.04 98.87 100 98.03 99.85 75.51 97.93 96.51 93.83 [91.10∼96.58] (p < 0.001) 0.96 0.00 8.91
Ours 97.17 95.86 98.88 98.99 97.49 99.93 100 99.61 100 81.19 100 97.71 95.21 [92.81∼97.26] 2.83 4.15 1.57
TABLE II: Comparing our model with several competitors on patient-level diagnosis. ‘FPE’, ‘FNE’ and ‘FDPE’ denote the
metrics of false positive error, false negative error and false disease prediction error, respectively. The numbers in square
brackets represent the 95% confidence interval. ‘p’ means the p-value compared our model with other competitors.
Fig. 7: ROC plots for patient-level classification. Best viewed in color and zoom in.
Methods Epoch Input Size GPUs Time(h) Data
COVNet 110 4×3×64×256×256 4 ≈2.5 442
Med3D-50 220 6×1×128×256×256 6 ≈4.5 442
Med3D-18 220 8×1×128×256×256 4 ≈4 442
DeCovNet 220 16×1×128×256×256 4 ≈2.5 442
Slice-level 110 32×3×1×512×512 2 ≈2 70k
Patient-level 90 16×3072×N×1×1 1 ≈0.3 442
TABLE III: The comparison of computational costs, i.e., the
max training epoch, the input size, the required GPUs, training
time and the available training data, between our system and
several competitors. The shape of input size is B × C × T ×
H×W , where B, C, T , H , W mean the number of batch-size,
channel, slice, image height and width, respectively. The ‘N’
denotes the arbitrary number of slice when training patient-
level classification network and the unit of the ‘Data’ is the
slice/volume for ‘Slice-level’/other methods. Note that the
input size is limited to the GPU memory.
2) Slice-level Performance: Another advantage of our pro-
posed M3Lung-Sys is that we can flexibly switch whether
the input is CT slices or volumes, i.e., slice-level or patient-
level diagnosis. Naturally, we further evaluate our model on
slices, using the total of 48,818 CT slices from the four
categories (i.e., Healthy, COVID-19, H1N1 and CAP) for
testing. As shown in Figure 8, our model achieves 98.40%,
98.99%, 100.00% and 94.58% in AUC for the four categories,
respectively. This strongly demonstrates the superiority of our
proposed M3Lung-Sys on slice-level diagnosis.
D. Ablation Study
1) Improvements in Patient-level Classification Network: It
is worth mentioning that our proposed slice-level classifica-
tion network is strong and the extracted features are very
discriminative. Even without parameters, simple mathematic
operations can obtain competitive results on patient-level
diagnosis. Meanwhile, the proposed multi-scale mechanism
Fig. 8: ROC plots for slice-level classification.
and refinement and aggregation head are able to further
boost performance. To verify this, as shown in Table IV,
we conduct experiments to demonstrate improvements with
different variants of the patient-level classification network.
More specifically, ‘Non-parametric Assessment’ denotes a
simple variant without parameters for differential diagnosis
(we refer readers to I for details). ‘Max pooling’ indicates that
the input features are directly aggregated by a max pooling
operation. ‘Single-scale + A. Head’ refers to a variant without
the multi-scale mechanism (i.e., S=[3]) and feature refinement
module. ‘Multi-scale + A. Head’ is similar to the previous
model but applies the multi-scale strategy (i.e., S=[1,2,3,4]).
From the results in Table IV and Figure 9, we highlight
the following observations: (1) Using only the non-parametric
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Methods Accuracy FPE FNE FDPE
Non-parametric Assessment 94.18 [91.44∼97.58] (p < 0.001) 10.66 0.0 3.11
Max pooling 92.12 [89.04∼95.21] (p < 0.001) 2.91 6.15 4.12
Single-scale + A. Head 93.15 [90.06∼95.56] (p < 0.001) 4.95 5.32 2.59
Multi-scale + A. Head 94.18 [91.44∼96.58] (p < 0.001) 2.89 5.22 2.04
Multi-scale + R.&A. Head (Ours) 95.21 [92.81∼97.26] 2.83 4.15 1.57
TABLE IV: Improvements of different components in the patient-level classification network. ‘R.&A. Head’ is our proposed
refinement and aggregation head, and ‘A. Head’ is a variant without the refinement module. ‘Non-parametric Assessment’
denotes that we perform patient-level classification only with several non-parametric mathematical operations. ‘FPE’, ‘FNE’
and ‘FDPE’ indicate the metric of false positive error, false negative error and false disease prediction error, respectively.
The numbers in square brackets represent the 95% confidence interval. ‘p’ means the p-value compared our model with other
competitors.
Method Multi-task Attention Coordinate Accuracy FPE FNE FDPE
ResNet-50 89.04 [85.27∼92.47] (p < 0.001) 22.46 1.04 3.65
4 92.12 [89.04∼94.86] (p < 0.001) 13.40 0.00 4.74
4 4 93.49 [90.41∼95.89] (p < 0.001) 11.88 0.00 3.57
Ours 4 4 4 94.18 [91.44∼97.58] 10.66 0.00 3.11
TABLE V: Improvements of different components in the slice-level classification network. ‘FPE’, ‘FNE’ and ‘FDPE’ indicate
the metrics of false positive error, false negative error and false disease prediction error, respectively. The numbers in square
brackets represent the 95% confidence interval. ‘p’ means the p-value compared our model with other competitors.
assessment method, we can achieve competitive results of
94.18% in accuracy, which suggests the stronger feature rep-
resentations acquired by our slice-level classification network.
However, a big performance gap between ‘false positive error’
and ‘false negative error’ also reflects its inferior robustness,
since a higher value of hyper-parameter T may result in more
healthy cases being misdiagnosed due to some noise. (2) From
the results in the second row to the last, the performance on all
metrics improves gradually with more and more specifically
designed components, which clearly demonstrates the benefits
of our proposed feature refinement and aggregation head and
multi-scale mechanism. (3) We notice that the false positive
error gets worse when applying the method of ‘Single-scale
+ A. Head’, and it decreases dramatically when involving
multi-scale mechanism. We argue that this does not suggest
the inferiority of our proposed ‘A. Head’ (since the overall
accuracy is improved by 1%), but reflects the importance and
rationality of the multi-scale mechanism.
2) Improvements in Slice-level Classification Network: To
explicitly demonstrate the advantages of our improvements in
slice-level classification network, we compare it with several
competitors on patient-level diagnosis. Without loss of gen-
erality, we choose the method of non-parametric assessment
with T = 0.99 as the patient-level classification network.
Concretely, since the backbone of our slice-level classification
network is ResNet-50, which is widely adopted by other
works [30], [42], we directly train a vanilla ResNet-50 for four-
way classification as a baseline. Based on this, we conduct fur-
ther experiments by gradually adding different improvements,
including multi-task learning, lesion location (attention) maps
and coordinate maps.
All results are listed in Table V. Compared with the
baseline, our model achieves significant improvement in all
four metrics. For example, the overall accuracy is improved
from 89.04% to 94.18% and the proportion of false positive
is reduced effectively by 12 points. Although we obtain a few
Fig. 9: The ROC curves of different variants in patient-
level classification network. ‘R.&A. Head’ is our refinement
and aggregation head, and ‘A. Head’ is a variant without the
refinement module. Best viewed in color and zoom in.
more failure cases on false disease predication when utilizing
the multi-task mechanism, the number of both false positive
and false negative samples is dramatically reduced. The two-
task approach acting like a radiologist is expected to better
distinguish between healthy people and patients. Furthermore,
if we introduce the coordinate maps, fewer positive samples
are misclassified as the wrong type of disease and some
negative cases with noise are correctly diagnosed as positive,
resulting in a decrease in both false positive and false disease
prediction error. These results clearly suggest that the compo-
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nents in slice-level classification network play important roles
in extracting discriminative features, e.g., attention maps for
awareness of small lesions, and coordinate maps for capturing
location diversity among different types of pneumonia.
E. Visualizations of Lesion Localization
As one of its contributions, our M3Lung-Sys can implement
lesion localization using only category labels, i.e., weakly-
supervised learning. To qualitatively evaluate this, we ran-
domly select several CT slices of three categories from the
testing set, and show the visualizations of lesion location maps
in Figure 10. For each group, the left image is the raw CT slice
after lung cropping, and the right image depicts the detected
area of abnormality. Note that a warmer color indicates that
the corresponding region has a higher probability of being
infected. Several observations can be made from Figure 10:
1) First of all, the quality of location maps are competitive.
All highlighted areas are concentrated on the left or right
lung region, and most abnormal manifestations, such as
ground-glass capacities (GGO), are completely captured
by our model, which is trained without any pixel-level
or bounding box labels. In addition, there is no eccentric
area being mistaken as a lesion, such as vertebra, skin
or other tissues. Our system can even precisely detect
small lesions with relatively high response, as shown
in the top-right image of Figure 10 (a). Above all, our
system can achieve visual localization of abnormal areas
with good interpretability, which is crucial for assisting
clinicians in diagnosis and improving the efficiency of
medical systems.
2) Second, we found that the location map results are con-
sist with the experience or conclusions of radiologists.
Several studies have found that COVID-19 typically
presents GGO with or without consolidation in a pre-
dominantly peripheral distribution [63]–[65], which has
already been used as guidance for COVID-19 diagnosis
endorsed by the Society of Thoracic Radiology, the
American College of Radiology, and RSNA [66]. In con-
trast, H1N1 pneumonia most commonly presents a pre-
dominantly peribronchovascular distribution [67], [68].
Lobar or segmented consolidation and cavitation suggest
a bacterial etiology [10]. Therefore, the visualizations
of location maps can reflect the characteristics of lesion
distributions in some ways, which may be a valuable
indicator for clinicians in analyzing or differentiating
these three diseases.
To fully demonstrate the practicability and effectiveness of
our system, we further simulate its real-world application and
present the outputs, i.e., the diagnosis assessment of diseases
and the localization of lesions. Concretely, we randomly select
two COVID-19 patients, and feed their CT exams into our
system. The full outputs are illustrated in Figure 11 and 12.
Due to page limitation, we show a CT sequence by sampling
every five slices. The lesion location maps, with the predicted
slice-level diagnosis on the upper right, are attached at the
bottom of the corresponding raw CT slices. At the end of
the sequence, the probability of each category predicted by
Fig. 10: The visualizations of location maps from COVID-
19, H1N1 and CAP cases. Each row has four groups. In each
group, the left image is the raw CT slice and the right one
shows the abnormality areas. Best viewed in color and zoom
in.
Fig. 11: The visualizations of our system outputs for one
COVID-19 patient. We show a CT sequence by sampling every
five slices. The lesion location maps, with the predicted slice-
level diagnosis on the upper right, are attached at the bottom of
the corresponding raw CT slices. At the end of the sequence,
the probability of each category, predicted by the patient-level
classification network is provided, i.e., 0: Healthy; 1: COVID-
19; 2: H1N1; 3: CAP. Best viewed in color and zoom in.
10 M3LUNG-SYS: A DEEP LEARNING SYSTEM FOR MULTI-CLASS LUNG PNEUMONIA SCREENING FROM CT IMAGING
Fig. 12: The visualizations of our system outputs for one
COVID-19 patient. We show a CT sequence by sampling every
five slices. The lesion location maps, with the predicted slice-
level diagnosis on the upper right, are attached at the bottom of
the corresponding raw CT slices. At the end of the sequence,
the probability of each category, predicted by the patient-level
classification network is provided, i.e., 0: Healthy; 1: COVID-
19; 2: H1N1; 3: CAP. Best viewed in color and zoom in.
the patient-level classification network is provided (i.e., 0:
Healthy; 1: COVID-19; 2: H1N1; 3: CAP). As can be seen,
our system can accurately locate the lesion areas in each slice,
4 and these areas also have good continuity in sequence, which
are very important characteristics to assist the clinician in
diagnosing COVID-19.
V. DISCUSSION
In this paper, we proposed a multi-task multi-slice deep
learning system (M3Lung-Sys) to assist the work of clinicians
by simultaneously screening multi-class lung pneumonia, i.e.,
Healthy, COVID-19, H1N1 and CAP, and locating lesions
from both slice-level and patient-level CT exams. Different
from previous studies, which incur high hardware, time and
data costs to train 3D CNNs, our system divides this pro-
cedure into two stages: slice-level classification and patient-
level classification. We first utilize the slice-level classification
4For slices that are classified as Healthy, it detects and visualizes the areas
of ‘without lesions’ (described in Sec. III-B.2), so almost the entire image is
highlighted.
network to classify each CT slice. An introduced multi-
task learning mechanism makes our model diagnose like a
radiologist, first checking whether each CT slice contains
any abnormality, and then determining what kind of disease
it is. Both attention maps and coordinate maps are further
applied to provide awareness of small lesions and capture
location diversity among different types of pneumonia. With
the improvements provided by these components, our sys-
tem achieves a remarkable performance of 94.18% accuracy,
10.66% false positive error and 0.0% false negative error.
Then, to recover the temporal information in CT sequence
slices and enable CT volumes screening, we propose a patient-
level classification network, taking as input a volume of
CT slice features extracted from the slice-level classification
network. Such a network can achieve the feature interac-
tion and aggregation between different slices for patient-level
diagnosis. Consequently, it further promotes our system by
dramatically reducing the cases of false positive and false
disease predication and improving the accuracy by 1.1%.
Above all, from a clinical perspective, our system can
perform differential diagnosis with not only a single CT
slice, but also a CT volume. The combined outputs of risk
assessment (predicted diagnosis) and lesion location maps
make it more flexible and valuable to clinicians. For example,
they can easily estimate the percentage of infected lung areas
or quickly check the lesions at any time before making a
decision. As illustrated in Figure 11 and 12 , with these lesion
location maps, clinicians are able to understand why the deep
learning model gives such prediction, not just face a statistic.
Even with the outstanding performance, there are three
limitations remaining in our system that need to be improved.
First of all, it is very easy for clinicians to distinguish COVID-
19 from healthy cases. However, from Table 2, we find that
our system may still misclassify some healthy people. We
examine failure cases and find that the main challenge lies
in the pulsatile artifacts in pulmonary CT imaging. Second,
our framework, which contains slice-level and patient-level
classification networks, is not end-to-end trainable yet. Al-
though it just increases the negligible training and testing
time, we hope the end-to-end training manner would be more
conducive to the learning and combination of spatial and
temporal information. Third, our proposed localization maps
accurately show the location of abnormal regions, which are
valuable to clinicians in assisting diagnosis. However, they still
lack the ability to automatically visualize the unique lesions’
distributions for each disease.
In the future, we will attempt to tackle the first and third lim-
itation by improving the attention mechanism to enhance the
feature representations. Besides, developing the technology of
coordinate maps may be an optimal option. Frankly speaking,
the third obstacle is a very challenging and ideal objective, but
we will continuously promote research along this line. As for
the second limitation, we are going to polish our method into
a unified framework, through such training mechanism, both
spatial and temporal information can complement each other.
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VI. CONCLUSION
In conclusion, we proposed a novel multi-task multi-slice
deep learning system (M3Lung-Sys) for multi-class lung pneu-
monia screening from chest CT images. Different from pre-
vious 3D CNN approaches, which incur a substantial training
cost, our system utilizes two 2D CNN networks, i.e., slice-
level and patient-level classification networks, to handle the
discriminative feature learning from the spatial and temporal
domain, respectively. With these special designs, our system
can not only be trained with much less cost, including time,
data and GPU, but can also perform differential diagnosis with
either a single CT slice, or a CT volume. More importantly,
without any pixel-level annotation for training, our system
is able to simultaneously output the lesion localization for
each CT slice, which is valuable to clinicians for diagnosis,
allowing them to understand why our system gives a particular
prediction, rather than just being faced with a statistic. Ac-
cording to the remarkable experimental results on 292 testing
cases with multi-class lung pneumonia (102 healthy people, 96
COVID-19 patients, 41 H1N1 patients and 53 CAP patients),
our system has great potential for clinical application.
APPENDIX I
NON-PARAMETRIC ASSESSMENT
Given a volume of CT exam with N slices in sequence,
we feed them into our slice-level classification network to
obtain two kinds of probabilities for each slice, Plesion =
(P 0li , P
1
li
)Ni=1 and Pmulti−class = (P
0
mi , P
1
mi , P
2
mi , P
3
mi)
N
i=1,
where Plesion means the probability whether a CT slice
contains any lesion or not, and Pmulti−class denotes the
predicted probability of multi-class pneumonia assessment
(i.e., 0: Healthy; 1: COVID-19; 2: H1N1; 3: CAP). Then, we
derive the final probabilities of four classes for each slice from
Plesion and Pmulti−class, which can be expressed as follows,
p = (p0i , p
1
i , p
2
i , p
3
i )
N
i=1,
p0i =P
0
li
+ P 1li × P 0mi ,
p1i = P
1
li
× P 1mi , p2i = P 1li × P 2mi , p3i = P 1li × P 3mi .
(4)
Intuitively, if all or most of slices are predicted as Health,
the patient has a very high chance of being healthy. Otherwise,
he will be diagnosed as either COVID-10, H1N1 or CAP,
according to CT imaging manifestation. To simulate this
process, our proposed non-parametric holistic assessment on
patient-level can be formulated as follows,

Healthy, if
N0
N
> T
COVID-19, if
N0
N
≤ T, max (N1,N2,N3) == N1
H1N1, if
N0
N
≤ T, max (N1,N2,N3) == N2
CAP, if
N0
N
≤ T, max (N1,N2,N3) == N3
(5)
where Nk =
∑N
i=1 δ(max pi − pki ) and δ(∗) = 1 if ∗ = 0,
otherwise, δ(∗) = 0. T is a hyper-parameter to control the
degree of ‘most of’, that is, the proportion of healthy (normal)
slices. Normally, the chest CT slices of healthy people should
be nearly or completely all normal. Therefore, without loss
of generality, in this paper, we set it as a reasonable and
acceptable value, i.e., T = 0.99.
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